ATE210460T1 - Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben - Google Patents

Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben

Info

Publication number
ATE210460T1
ATE210460T1 AT96919136T AT96919136T ATE210460T1 AT E210460 T1 ATE210460 T1 AT E210460T1 AT 96919136 T AT96919136 T AT 96919136T AT 96919136 T AT96919136 T AT 96919136T AT E210460 T1 ATE210460 T1 AT E210460T1
Authority
AT
Austria
Prior art keywords
adp
production
methods
transferase activity
compositions exhibiting
Prior art date
Application number
AT96919136T
Other languages
English (en)
Inventor
Harvey R Kaslow
Original Assignee
Harvey R Kaslow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvey R Kaslow filed Critical Harvey R Kaslow
Application granted granted Critical
Publication of ATE210460T1 publication Critical patent/ATE210460T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT96919136T 1995-06-07 1996-06-04 Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben ATE210460T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/482,758 US6056960A (en) 1995-06-07 1995-06-07 Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
PCT/US1996/009174 WO1996040228A1 (en) 1995-06-07 1996-06-04 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof

Publications (1)

Publication Number Publication Date
ATE210460T1 true ATE210460T1 (de) 2001-12-15

Family

ID=23917340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919136T ATE210460T1 (de) 1995-06-07 1996-06-04 Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben

Country Status (8)

Country Link
US (3) US6056960A (de)
EP (1) EP0836480B1 (de)
JP (1) JPH11512076A (de)
AT (1) ATE210460T1 (de)
AU (1) AU6176596A (de)
CA (1) CA2224160A1 (de)
DE (1) DE69617956T2 (de)
WO (1) WO1996040228A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10010165A1 (de) * 2000-03-01 2001-09-20 Hartmut Merz C O Medizinische Mittel zur Tumorbekämpfung
US20020001805A1 (en) * 2000-03-14 2002-01-03 Roden Richard Bruce Immunogenic ovarian cancer genes
US20030162733A1 (en) * 2000-11-27 2003-08-28 Haynes Joel R. Nucleic acid adjuvants
DE60139959D1 (de) * 2000-11-27 2009-10-29 Powderject Vaccines Inc Nukleinsäureadjuvantien
US20070156720A1 (en) * 2005-08-31 2007-07-05 Eagleforce Associates System for hypothesis generation
JP5239041B2 (ja) * 2007-02-07 2013-07-17 一般財団法人阪大微生物病研究会 癌の治療剤
GB201907413D0 (en) * 2019-05-24 2019-07-10 Univ Helsinki Viral vector

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372945A (en) * 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
ZA885929B (en) * 1987-08-25 1989-04-26 Oxi Gene Inc Agents for use in tumor or cancer cell killing therapy

Also Published As

Publication number Publication date
EP0836480A4 (de) 1999-02-03
AU6176596A (en) 1996-12-30
WO1996040228A1 (en) 1996-12-19
US6514499B1 (en) 2003-02-04
US6056960A (en) 2000-05-02
DE69617956T2 (de) 2004-08-19
CA2224160A1 (en) 1996-12-19
EP0836480A1 (de) 1998-04-22
DE69617956D1 (de) 2002-01-24
US20030113311A1 (en) 2003-06-19
JPH11512076A (ja) 1999-10-19
US7341733B2 (en) 2008-03-11
EP0836480B1 (de) 2001-12-12

Similar Documents

Publication Publication Date Title
FI963070A0 (fi) Klooripyrimidiinivälituotteita
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
RU94036748A (ru) Церамиды, способ их получения, композиция на их основе и способ гидратирующей обработки кожи или волос
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
NO20002788D0 (no) Nye forbindelser
ATE180776T1 (de) Naphthylverbindungen, zwischenprodukte, zusammensetzungen und methoden
EP1409544A4 (de) Humane dr4-antikörper und deren anwendungen
EP0675904A4 (de) Humane neutralisierende monoklonale antikörper gegen den die immunschwäche auslösenden virus aus mensch.
ATE510552T1 (de) Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
FI972703A0 (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
ATE287949T1 (de) Löslicher komplex morphogener proteine und zusammensetzungen davon
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
IT1231126B (it) Procedimento per la produzione di impiallacciatura artificiale ad imitazione della radica, mediante bruciature.
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
DE59610251D1 (de) Konjugat, umfassend einen wirkstoff, ein polypeptid und einen polyether
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
DE69617956D1 (de) Zusammensetzungen, welche adp-ribosyltransferase-aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben
BG105275A (en) Tan-1057 derivatives
ES2192610T3 (es) Aminouracilos substituidos.
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
ATE91689T1 (de) Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel.
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties